Immunology Research
To learn more about immune system conditions and ongoing clinical trials in this area, visit our Immunology Research page.
Learn MoreThe main purpose of this study is to measure the effect, safety and how well the body absorbs Lebrikizumab in pediatric participants 6 months to <18 years of age with moderate-to-severe atopic dermatitis (AD).
Have Atopic Dermatitis for at least 6 months if younger than 6 years old or 1 year if older than 6 years
6 months to 12 years old and weigh over 6 kilograms
12 to 18 years old and weigh less than 40 kilograms
A parent or legal guardian must be able to sign the consent document and follow to the guidelines of the study
And meet other additional conditions at the time of the first visit
Have been in a similar study with a similar drug or received a forbidden treatment within the last 2 - 8 weeks
Be pregnant or breastfeeding
Have had previous reaction to the study drug or the ointments or cremes used in this study
Have a severe or current infection that requires strong antibiotics
Have a history of or have a current disease, or type of illness that your doctor believes could affect your safety
Have an addiction to drugs or alcohol
To learn more about immune system conditions and ongoing clinical trials in this area, visit our Immunology Research page.
Learn MoreTo learn more about pediatric clinical trials, and access resources for children, young people, and caregivers, visit our Pediatric Research page.
Learn MoreA clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.